Sfe Investment Counsel Illumina, Inc. Transaction History

Sfe Investment Counsel

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$128.91 - $192.44 $5,800 - $8,659	45 Added 2.67%	1,730 $237,000
Q2 2023 Jul 24, 2023	BUY	$183.43 - $232.67 $6,420 - $8,143	35 Added 2.12%	1,685 $315,000
Q4 2022 Feb 09, 2023	SELL	$187.24 - $242.74 $20,596 - $26,701	-110 Reduced 6.25%	1,650 $333,000
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $115,199 - $147,836	650 Added 58.56%	1,760 $336,000
Q2 2022 Aug 10, 2022	BUY	$181.58 - $368.0 $201,553 - $408,480	1,110 New	1,110 $205,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Sfe Investment Counsel with notifications on news.